HIV Transmission & Prevention Perspective

 
 
  • Does Your Patient Have Latent TB Infection? Test Your Knowledge Learn how to identify and treat latent tuberculosis infection, thereby preventing TB disease and accelerating progress toward elimination.
  • HIV and AIDS: Overview Video   Review key aspects of HIV and AIDS —including transmission, disease progression, and prevention and treatment—with this quick overview video.
  • ANAC 2020 Read clinically focused news coverage of key developments from ANAC 2020
  • USCHA 2020 Read clinically focused news coverage of key developments from USCA 2020
  • HIV Glasgow 2020 Read clinically focused news coverage of key developments from HIV Glasgow 2020
  • Are New COVID-19 Treatments More Important Than a Vaccine?   WebMD Chief Medical Officer John Whyte talks with Dr Davey Smith about why developing early therapies for COVID-19 may be more important than creating a vaccine.
  • Confronting the HIV Epidemic: Taking Down Silos   Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic.
  • PrEP During COVID-19: 5 Things to Know Accessing care at the places where PrEP is prescribed is harder to do during a pandemic. Here are five things to know about PrEP in the era of COVID-19.
  • Confronting the HIV Epidemic: There's an App for That   UNC physicians and scientists use mobile app technology and gamification strategy to engage at-risk and HIV-positive young men in prevention and management of HIV.
  • AIDS 2020 Read clinically focused news coverage of key developments from IAS 2020
  • PrEP Is Highly Effective; How Can We Increase Adoption? Preexposure prophylaxis has been proven to be effective when taken consistently, but treatment uptake and retention are low. What can clinicians do to expand HIV prevention?
  • Long-acting Injectable Cabotegravir for PrEP Is Promising   Dr Paul Sax discusses the interim results from a study on the use of the long-acting injectable cabotegravir for pre-exposure prophylaxis in cisgender men and transgender women who have sex with men.
  • Why Don't We Have a Vaccine for SARS or MERS? We don't have vaccines for SARS, MERS, or HIV. Does that spell doom for efforts to develop a vaccine for SARS-CoV-2?
  • Confronting the HIV Epidemic   Infectious disease experts from UNC Chapel Hill have developed innovative methods to engage young minority men, the fastest-growing HIV-positive population, in the prevention and treatment of HIV.
  • CROI 2020 Read clinically focused news coverage of key developments from CROI 2020
  • EACS 2019 Read clinically focused news coverage of key developments from EACS 2019
  • ANAC 2019 Read clinically focused news coverage of key developments from ANAC 2019
  • Staying Golden: Aging With HIV: The Way Forward   A longtime HIV/AIDS researcher and clinician maps out potential ways to approach a curative strategy, and comments on the need for global resources and support.
  • USCA 2019 Read clinically focused news coverage of key developments from UCSA 2019
  • Staying Golden: Aging With HIV: Finding True North   Experts address HIV prevention and screening in the older adult population, as well as strategies for assessing complications in aging HIV patients.